Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
AVANIR PHARMACEUTICALS, INC. (AVNR)
| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 12/18/2014 | Siffert Joao MD | SVP, R&D | Payment of Exercise | Common Stock | 19.2k | $16.99 | $326.3k | | 12/18/2014 |
| 12/18/2014 | Siffert Joao MD | SVP, R&D | Sale | Common Stock | 15.5k | $16.93 | $262.5k | | 12/18/2014 |
| 12/18/2014 | Siffert Joao MD | SVP, R&D | Exercise | Stock Option (right to buy) | 32.3k | $2.59 | $83.6k | | 12/18/2014 |
| 12/18/2014 | OCAMPO CHRISTINE | Vice President, Finance | Sale | Common Stock | 5.8k | $16.93 | $97.9k | | 12/16/2014 |
| 12/17/2014 | Katkin Keith | President and CEO | Sale | Common Stock | 62.5k | $16.93 | $1.1M | | 12/15/2014 |
| 12/16/2014 | OCAMPO CHRISTINE | Vice President, Finance | Sale | Common Stock | 12.5k | $16.94 | $211.8k | | 12/16/2014 |
| 12/16/2014 | OCAMPO CHRISTINE | Vice President, Finance | Sale | Common Stock | 17.5k | $16.94 | $296.4k | | 12/16/2014 |
| 12/16/2014 | OCAMPO CHRISTINE | Vice President, Finance | Exercise | Stock Option (Right to Buy) | 12.5k | $2.59 | $32.4k | | 12/16/2014 |
| 12/16/2014 | OCAMPO CHRISTINE | Vice President, Finance | Exercise | Stock Option (Right to Buy) | 17.5k | $4.18 | $73.2k | | 12/16/2014 |
| 12/15/2014 | Katkin Keith | President and CEO | Exercise | Stock Option (right to buy) | 56k | $1.29 | $72.2k | | 12/15/2014 |
| 12/15/2014 | Katkin Keith | President and CEO | Exercise | Stock Option (right to buy) | 139.2k | $1.74 | $242.2k | | 12/15/2014 |
| 12/15/2014 | Katkin Keith | President and CEO | Sale | Common Stock | 20k | $16.95 | $339k | | 12/15/2014 |
| 12/15/2014 | Katkin Keith | President and CEO | Sale | Common Stock | 195.2k | $16.95 | $3.3M | | 12/15/2014 |
| 11/28/2014 | PALEKAR ROHAN | SVP & Chief Commercial Officer | Sale | Common Stock | 15k | $15.00 | $225k | | 11/28/2014 |
| 11/28/2014 | PALEKAR ROHAN | SVP & Chief Commercial Officer | Exercise | Stock Option (right to buy) | 15k | $3.38 | $50.7k | | 11/28/2014 |
| 11/10/2014 | OCAMPO CHRISTINE | Vice President, Finance | Grant | Common Stock | 32k | $0.00 | $0 | | 11/10/2014 |
| 11/10/2014 | OCAMPO CHRISTINE | Vice President, Finance | Grant | Common Stock | 19.8k | $0.00 | $0 | | 11/10/2014 |
| 11/10/2014 | Siffert Joao MD | SVP, R&D | Grant | CommonStock | 59.2k | $0.00 | $0 | | 11/10/2014 |
| 11/10/2014 | Siffert Joao MD | SVP, R&D | Grant | Common Stock | 34.8k | $0.00 | $0 | | 11/10/2014 |
| 11/10/2014 | PALEKAR ROHAN | SVP & Chief Commercial Officer | Grant | Common Stock | 59.2k | $0.00 | $0 | | 11/10/2014 |
| 11/10/2014 | PALEKAR ROHAN | SVP & Chief Commercial Officer | Grant | Common Stock | 34.8k | $0.00 | $0 | | 11/10/2014 |
| 11/10/2014 | Katkin Keith | President and CEO | Grant | Common Stock | 220.6k | $0.00 | $0 | | 11/10/2014 |
| 11/10/2014 | Katkin Keith | President and CEO | Grant | Common Stock | 140.6k | $0.00 | $0 | | 11/10/2014 |
| 10/24/2014 | Katkin Keith | President and CEO | Sale | Common Stock | 27.6k | $11.76 | $324.2k | | 10/24/2014 |
| 10/24/2014 | Siffert Joao MD | SVP, R&D | Sale | Common Stock | 8.4k | $11.80 | $99.4k | | 10/24/2014 |
| 10/24/2014 | OCAMPO CHRISTINE | Vice President, Finance | Sale | Common Stock | 2.1k | $11.81 | $24.6k | | 10/24/2014 |
| 09/15/2014 | PALEKAR ROHAN | SVP & Chief Commercial Officer | Sale | Common Stock | 10k | $10.00 | $100k | | 09/15/2014 |
| 09/15/2014 | PALEKAR ROHAN | SVP & Chief Commercial Officer | Sale | Common Stock | 15k | $12.50 | $187.5k | | 09/15/2014 |
| 09/15/2014 | PALEKAR ROHAN | SVP & Chief Commercial Officer | Exercise | Stock Option (right to Buy) | 25k | $3.38 | $84.5k | | 09/15/2014 |
| 09/15/2014 | OCAMPO CHRISTINE | Vice President, Finance | Sale | Common Stock | 55k | $9.45 | $519.8k | | 09/15/2014 |
| 09/15/2014 | OCAMPO CHRISTINE | Vice President, Finance | Exercise | Stock Option (right to Buy) | 55k | $4.18 | $229.9k | | 09/15/2014 |
| 08/26/2014 | OCAMPO CHRISTINE | Vice President, Finance | Sale | Common Stock | 2.1k | $6.10 | $12.9k | | 08/26/2014 |
| 08/01/2014 | Katkin Keith | President and CEO | Sale | Common Stock | 9.7k | $5.26 | $50.9k | | 08/01/2014 |
| 07/09/2014 | Katkin Keith | President and CEO | Grant | Common Stock | 20k | $0.00 | $0 | | 07/09/2014 |
| 05/28/2014 | Siffert Joao MD | SVP, R&D | Sale | Common Stock | 13.5k | $5.18 | $70.2k | | 05/28/2014 |
|
|